Effects of Miglitol, Acarbose, and Sitagliptin on Plasma Insulin and Gut Peptides in Type 2 Diabetes Mellitus: A Crossover Study

Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

(2015) M. A. Bethel et al.   DIABETES OBESITY & METABOLISM

A nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patients

(2015) K. Esposito et al.   BMJ Open

Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans

(2014) Monika J Bak et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Distinct action of the α-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion

(2014) Eun Young Lee et al.   JOURNAL OF ENDOCRINOLOGY

Diabetes: a 21st century challenge

(2013) Paul Z Zimmet et al.   Lancet Diabetes & Endocrinology

Anorexigenic Effects of Miglitol in Concert with the Alterations of Gut Hormone Secretion and Gastric Emptying in Healthy Subjects

(2012) H. Kaku et al.   HORMONE AND METABOLIC RESEARCH

Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus

(2012) Thomas Rauch et al.   Diabetes Therapy

Comparisons of the effects of 12-week administration of miglitol and voglibose on the responses of plasma incretins after a mixed meal in Japanese type 2 diabetic patients

(2011) T. Narita et al.   DIABETES OBESITY & METABOLISM

Effect of sitagliptin monotherapy on serum total ghrelin levels in people with type 2 diabetes

(2011) Özen Öz Gül et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Analysis of plasma ghrelin in patients with medium-chain acyl-CoA dehydrogenase deficiency and glutaric aciduria type II

(2011) Takashi Akamizu et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes

(2011) Daisuke Yabe et al.   Journal of Diabetes Investigation

Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitus

(2011) Chrysi Koliaki et al.   Diabetes Therapy

Incretin responses to oral glucose load in Japanese non-obese healthy subjects

(2011) Etsuko Nagai et al.   Diabetes Therapy

Carbohydrate and fat digestion is necessary for maximal suppression of total plasma ghrelin in healthy adults

(2010) Kamilia Tai et al.   APPETITE

Single Administration of α-Glucosidase Inhibitors on Endothelial Function and Incretin Secretion in Diabetic Patients With Coronary Artery Disease

(2010) Makoto Hiki et al.   CIRCULATION JOURNAL

Dipeptidyl Peptidase-4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP-1

(2010) E M Migoya et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effects of miglitol, sitagliptin or their combination on plasma glucose, insulin and incretin levels in non-diabetic men

(2010) Kazutaka Aoki et al.   ENDOCRINE JOURNAL

Preprandial Single Oral Dose of Sitagliptin Does Not Affect Circulating Ghrelin and Gastrin Levels in Normal Subjects

(2010) Chen-Ling Huang et al.   PHARMACOLOGY

Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications

(2009) N. Irwin et al.   DIABETOLOGIA

Miglitol induces prolonged and enhanced glucagon-like peptide-1 and reduced gastric inhibitory polypeptide responses after ingestion of a mixed meal in Japanese Type 2 diabetic patients

(2008) T. Narita et al.   DIABETIC MEDICINE

Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects

(2008) Masayuki Arakawa et al.   METABOLISM-CLINICAL AND EXPERIMENTAL